Form D · Biotechnology
NITROME BIOSCIENCES, INC
Jackson, WY · CIK 0001746366
Offering snapshot reported Apr 22, 2020 · SEC filing
- Reported sold
- $17.1M Offering amount: $47.5M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 8, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 22, 2020 | Initial | $17,135,023 | No comparison | 18 | SEC filing |
| Jul 1, 2019 | Initial | $500,000 | No comparison | 9 | SEC filing |
| Jan 7, 2019 | Initial | $400,000 | No comparison | 8 | SEC filing |
| Jul 13, 2018 | Initial | $104,584 | No comparison | 5 | SEC filing |
| Jul 13, 2018 | Initial | $750,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-365579
Source: Form D, filed Apr 22, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jonathan Behr | Director |
| Margarita Chavez | Director |
| Irene Griswold Prenner | Director, Executive |
| Zach Hall | Director |
| Ephraim Heller | Director |
| Ephreim Heller | Director |
| Regis Kelly | Director |
| William Mc Dowell | Director |
| Henrijette Richter | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
435 Henley Rd P.O. Box 4971
Jackson, WY, 83001
Jackson, WY, 83001